However, BRCA1 carriers were more likely to have triple negative breast cancer (p=0.002) and BRCA2 carriers were more likely to have luminal B breast cancer tumors (p=0.000078). This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.